Growth Metrics

DBV Technologies (DBVT) Total Current Liabilities (2014 - 2026)

DBV Technologies (DBVT) reported Total Current Liabilities of $51.8 million for Q1 2026, up 28.27% year-over-year from $40.4 million in Q1 2025, and down 10.69% on a QoQ basis from $58.0 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Total Current Liabilities data on file, last reported at $51.8 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 28.27% year-over-year to $51.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.8 million (up 28.27% YoY) and the FY2025 annual result came in at $58.0 million, up 86.28% from the prior year.
  • Total Current Liabilities eased to $51.8 million in Q1 2026 per DBVT's latest filing, from $58.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $58.0 million in Q4 2025 and bottomed at $26.0 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $31.4 million (2023), against an average of $36.1 million.
  • The widest annual swing landed in 2022, when Total Current Liabilities sank 32.96%; it then soared 86.28% in 2025.
  • Tracing DBVT's Total Current Liabilities over 5 years: stood at $29.5 million in 2022, then rose by 26.48% to $37.3 million in 2023, then retreated by 16.61% to $31.1 million in 2024, then surged by 86.28% to $58.0 million in 2025, then dropped by 10.69% to $51.8 million in 2026.
  • Per Business Quant, the three latest DBVT Total Current Liabilities figures stand at $51.8 million (Q1 2026), $58.0 million (Q4 2025), and $49.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 51.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 51.80 Mn
Dec 31, 2025 58.00 Mn
Sep 30, 2025 49.49 Mn
Jun 30, 2025 49.43 Mn
Mar 31, 2025 40.38 Mn
Dec 31, 2024 31.14 Mn
Sep 30, 2024 30.91 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 26.48 Mn
Dec 31, 2023 37.34 Mn
Sep 30, 2023 31.44 Mn
Jun 30, 2023 33.37 Mn
Mar 31, 2023 32.78 Mn
Dec 31, 2022 29.52 Mn
Sep 30, 2022 28.39 Mn
Jun 30, 2022 30.43 Mn
Mar 31, 2022 26.03 Mn
Dec 31, 2021 31.40 Mn
Sep 30, 2021 33.81 Mn
Jun 30, 2021 38.70 Mn
Mar 31, 2021 38.83 Mn
Dec 31, 2020 52.71 Mn
Jun 30, 2020 61.22 Mn
Dec 31, 2019 53.21 Mn
Sep 30, 2019 49.37 Mn
Jun 30, 2019 51.46 Mn
Dec 31, 2018 49.70 Mn
Jun 30, 2018 41.68 Mn
Dec 31, 2017 42.31 Mn
Jun 30, 2017 35.74 Mn
Dec 31, 2016 31.31 Mn
Jun 30, 2016 27.71 Mn
Dec 31, 2015 17.56 Mn
Jun 30, 2015 8.74 Mn
Dec 31, 2014 6.94 Mn